• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氧化应激在糖尿病肾病发病机制中的研究进展及中医药干预的疗效。

Advances in oxidative stress in pathogenesis of diabetic kidney disease and efficacy of TCM intervention.

机构信息

School of Basic Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

School of Public Health, Chengdu University of Traditional Chinese Medicine, Chengdu, China.

出版信息

Ren Fail. 2023 Dec;45(1):2146512. doi: 10.1080/0886022X.2022.2146512.

DOI:10.1080/0886022X.2022.2146512
PMID:36762989
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9930779/
Abstract

Diabetic kidney disease (DKD) is a common complication of diabetes and has become the leading cause of end-stage kidney disease. The pathogenesis of DKD is complicated, and oxidative stress is considered as a core of DKD onset. High glucose can lead to increased production of reactive oxygen species (ROS) the polyol, PKC, AGE/RAGE and hexosamine pathways, resulting in enhanced oxidative stress response. In this way, pathways such as PI3K/Akt, TGF-β1/p38-MAPK and NF-κB are activated, inducing endothelial cell apoptosis, inflammation, autophagy and fibrosis that cause histologic and functional abnormalities of the kidney and finally result in kidney injury. Presently, the treatment for DKD remains an unresolved issue. Traditional Chinese medicine (TCM) has unique advantages for DKD prevention and treatment attributed to its multi-target, multi-component, and multi-pathway characteristics. Numerous studies have proved that Chinese herbs (e.g., Golden Thread, Kudzuvine Root, Tripterygium glycosides, and Ginseng) and patent medicines (e.g., Shenshuaining Tablet, Compound Rhizoma Coptidis Capsule, and Zishen Tongluo Granule) are effective for DKD treatment. The present review described the role of oxidative stress in DKD pathogenesis and the effect of TCM intervention for DKD prevention and treatment, in an attempt to provide evidence for clinical practice.

摘要

糖尿病肾病(DKD)是糖尿病的常见并发症,已成为终末期肾病的主要原因。DKD 的发病机制复杂,氧化应激被认为是 DKD 发病的核心。高血糖可导致活性氧(ROS)的产生增加、多元醇、蛋白激酶 C(PKC)、晚期糖基化终末产物(AGE)/受体(RAGE)和己糖胺途径,从而增强氧化应激反应。这样,PI3K/Akt、转化生长因子-β1/p38-MAPK 和 NF-κB 等途径被激活,诱导内皮细胞凋亡、炎症、自噬和纤维化,导致肾脏的组织学和功能异常,最终导致肾脏损伤。目前,DKD 的治疗仍然是一个未解决的问题。由于具有多靶点、多成分、多途径的特点,中医药在 DKD 的防治方面具有独特的优势。大量研究证明,中药(如金线莲、葛根、雷公藤多苷、人参)和专利药(如肾衰宁片、复方黄连胶囊、 滋肾通络颗粒)对 DKD 的治疗有效。本综述描述了氧化应激在 DKD 发病机制中的作用以及中医药干预 DKD 的防治作用,以期为临床实践提供证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63e0/9930779/a735cf29af8b/IRNF_A_2146512_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63e0/9930779/a735cf29af8b/IRNF_A_2146512_F0001_C.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/63e0/9930779/a735cf29af8b/IRNF_A_2146512_F0001_C.jpg

相似文献

1
Advances in oxidative stress in pathogenesis of diabetic kidney disease and efficacy of TCM intervention.氧化应激在糖尿病肾病发病机制中的研究进展及中医药干预的疗效。
Ren Fail. 2023 Dec;45(1):2146512. doi: 10.1080/0886022X.2022.2146512.
2
Oxidative Stress: A Culprit in the Progression of Diabetic Kidney Disease.氧化应激:糖尿病肾病进展的罪魁祸首。
Antioxidants (Basel). 2024 Apr 12;13(4):455. doi: 10.3390/antiox13040455.
3
Advances in Traditional Chinese Medicine research in diabetic kidney disease treatment.糖尿病肾病治疗中中医药研究进展。
Pharm Biol. 2024 Dec;62(1):222-232. doi: 10.1080/13880209.2024.2314705. Epub 2024 Feb 15.
4
Jiedu Tongluo Baoshen formula enhances podocyte autophagy and reduces proteinuria in diabetic kidney disease by inhibiting PI3K/Akt/mTOR signaling pathway.解毒通络保肾方通过抑制PI3K/Akt/mTOR信号通路增强足细胞自噬并减少糖尿病肾病中的蛋白尿。
J Ethnopharmacol. 2022 Jul 15;293:115246. doi: 10.1016/j.jep.2022.115246. Epub 2022 Apr 7.
5
AGE/RAGE in diabetic kidney disease and ageing kidney.AGE/RAGE 在糖尿病肾病和老化肾脏中的作用。
Free Radic Biol Med. 2021 Aug 1;171:260-271. doi: 10.1016/j.freeradbiomed.2021.05.025. Epub 2021 May 18.
6
The mechanisms underlying Chinese medicines to treat inflammation in diabetic kidney disease.中药治疗糖尿病肾病炎症的潜在机制。
J Ethnopharmacol. 2024 Oct 28;333:118424. doi: 10.1016/j.jep.2024.118424. Epub 2024 Jun 4.
7
Traditional Chinese medicine improved diabetic kidney disease through targeting gut microbiota.中医通过靶向肠道微生物群改善糖尿病肾病。
Pharm Biol. 2024 Dec;62(1):423-435. doi: 10.1080/13880209.2024.2351946. Epub 2024 May 17.
8
Mechanisms and efficacy of traditional Chinese herb monomers in diabetic kidney disease.中药单体治疗糖尿病肾病的机制与疗效。
Int Urol Nephrol. 2024 Feb;56(2):571-582. doi: 10.1007/s11255-023-03703-0. Epub 2023 Aug 8.
9
Mechanism underlying treatment of diabetic kidney disease using Traditional Chinese Medicine based on theory of Yin and Yang balance.基于阴阳平衡理论的中医药治疗糖尿病肾病的机制。
J Tradit Chin Med. 2018 Oct;38(5):797-802.
10
[Potential pathways for traditional Chinese medicine intervention in diabetic kidney disease: macrophage polarization].[中药干预糖尿病肾病的潜在途径:巨噬细胞极化]
Zhongguo Zhong Yao Za Zhi. 2024 Aug;49(15):4044-4053. doi: 10.19540/j.cnki.cjcmm.20240412.708.

引用本文的文献

1
FoxO3a: capture the bond between magnesium and diabetic kidney disease.叉头框蛋白O3a:揭示镁与糖尿病肾病之间的关联
Front Endocrinol (Lausanne). 2025 Aug 13;16:1603150. doi: 10.3389/fendo.2025.1603150. eCollection 2025.
2
Empagliflozin alleviates type 2 diabetic renal fibrosis by inhibiting SLC7A7-mediated ferroptosis.恩格列净通过抑制SLC7A7介导的铁死亡来减轻2型糖尿病肾纤维化。
Diabetol Metab Syndr. 2025 Aug 13;17(1):329. doi: 10.1186/s13098-025-01902-6.
3
Pathophysiological Mechanisms of Diabetes-Induced Macrovascular and Microvascular Complications: The Role of Oxidative Stress.

本文引用的文献

1
Polyol pathway and redox balance in diabetes.多元醇途径和糖尿病中的氧化还原平衡。
Pharmacol Res. 2022 Aug;182:106326. doi: 10.1016/j.phrs.2022.106326. Epub 2022 Jun 22.
2
Quality of Evidence Supporting the Role of Tripterygium Glycosides for the Treatment of Diabetic Kidney Disease: An Overview of Systematic Reviews and Meta-Analyses.证据质量支持雷公藤苷治疗糖尿病肾病的作用:系统评价和荟萃分析概述。
Drug Des Devel Ther. 2022 May 31;16:1647-1665. doi: 10.2147/DDDT.S367624. eCollection 2022.
3
Antioxidant and Anti-inflammatory Properties of Resveratrol in Diabetic Nephropathy: A Systematic Review and Meta-analysis of Animal Studies.
糖尿病诱导的大血管和微血管并发症的病理生理机制:氧化应激的作用
Med Sci (Basel). 2025 Jul 2;13(3):87. doi: 10.3390/medsci13030087.
4
Targeting ion channel networks in diabetic kidney disease: from molecular crosstalk to precision therapeutics and clinical innovation.靶向糖尿病肾病中的离子通道网络:从分子串扰到精准治疗与临床创新
Front Med (Lausanne). 2025 Jun 26;12:1607701. doi: 10.3389/fmed.2025.1607701. eCollection 2025.
5
Traditional Chinese medicine in diabetic kidney disease: multifaceted therapeutic mechanisms and research progress.糖尿病肾病中的中医药:多方面治疗机制及研究进展
Chin Med. 2025 Jul 1;20(1):95. doi: 10.1186/s13020-025-01150-w.
6
Natural therapy proposed for the management of diabetic peripheral neuropathy (DPN).提出用于治疗糖尿病周围神经病变(DPN)的自然疗法。
Inflammopharmacology. 2025 May 30. doi: 10.1007/s10787-025-01790-2.
7
Mechanism Analysis of Zuogui and Yougui Pills on Diabetic Nephropathy Through Transcriptional Regulatory Networks of HIF1A and PPARA.基于HIF1A和PPARA转录调控网络探讨左归丸和右归丸对糖尿病肾病作用机制的分析
Food Sci Nutr. 2025 May 23;13(6):e70317. doi: 10.1002/fsn3.70317. eCollection 2025 Jun.
8
Celastrol protects against diabetic nephropathy by modulating immune-related pathways: a bioinformatics and experimental validation.雷公藤红素通过调节免疫相关途径预防糖尿病肾病:生物信息学及实验验证
Am J Transl Res. 2025 Apr 15;17(4):2467-2483. doi: 10.62347/CBIP6642. eCollection 2025.
9
Plasma proteome signatures of ASK1 inhibition by selonsertib associate with efficacy in the MOSAIC randomized trial for diabetic kidney disease.在糖尿病肾病的MOSAIC随机试验中,塞洛西布抑制ASK1的血浆蛋白质组特征与疗效相关。
BMC Nephrol. 2025 May 15;26(1):244. doi: 10.1186/s12882-025-04166-4.
10
mTOR-mediated nutrient sensing and oxidative stress pathways regulate autophagy: a key mechanism for traditional Chinese medicine to improve diabetic kidney disease.mTOR介导的营养感知和氧化应激途径调节自噬:中药改善糖尿病肾病的关键机制。
Front Pharmacol. 2025 Apr 23;16:1578400. doi: 10.3389/fphar.2025.1578400. eCollection 2025.
白藜芦醇在糖尿病肾病中的抗氧化和抗炎特性:动物研究的系统评价与荟萃分析
Front Pharmacol. 2022 Mar 9;13:841818. doi: 10.3389/fphar.2022.841818. eCollection 2022.
4
Independent of Renox, NOX5 Promotes Renal Inflammation and Fibrosis in Diabetes by Activating ROS-Sensitive Pathways.独立于 Renox,NOX5 通过激活 ROS 敏感途径促进糖尿病中的肾脏炎症和纤维化。
Diabetes. 2022 Jun 1;71(6):1282-1298. doi: 10.2337/db21-1079.
5
Effect of Polysaccharide on Decreasing Serum Amyloid A3 Expression through Inhibiting NF-B Activation in a Mouse Model of Diabetic Nephropathy.多糖通过抑制糖尿病肾病小鼠模型中 NF-B 的激活降低血清淀粉样蛋白 A3 的表达。
Anal Cell Pathol (Amst). 2022 Jan 29;2022:7847135. doi: 10.1155/2022/7847135. eCollection 2022.
6
Ginsenoside Rg1 attenuates the inflammation and oxidative stress induced by diabetic nephropathy through regulating the PI3K/AKT/FOXO3 pathway.人参皂苷Rg1通过调节PI3K/AKT/FOXO3信号通路减轻糖尿病肾病诱导的炎症和氧化应激。
Ann Transl Med. 2021 Dec;9(24):1789. doi: 10.21037/atm-21-6234.
7
Ginsenoside Rb1 alleviates diabetic kidney podocyte injury by inhibiting aldose reductase activity.人参皂苷 Rb1 通过抑制醛糖还原酶活性减轻糖尿病肾病足细胞损伤。
Acta Pharmacol Sin. 2022 Feb;43(2):342-353. doi: 10.1038/s41401-021-00788-0. Epub 2021 Nov 22.
8
UHPLC-MS-Based Serum and Urine Metabolomics Reveals the Anti-Diabetic Mechanism of Ginsenoside Re in Type 2 Diabetic Rats.基于 UHPLC-MS 的血清和尿液代谢组学揭示了人参皂苷 Re 在 2 型糖尿病大鼠中的抗糖尿病作用机制。
Molecules. 2021 Nov 3;26(21):6657. doi: 10.3390/molecules26216657.
9
Efficacy and safety of Huangkui capsule for diabetic nephropathy: A protocol for systematic review and meta-analysis.黄葵胶囊治疗糖尿病肾病的疗效和安全性的系统评价和荟萃分析方案。
Medicine (Baltimore). 2021 Oct 22;100(42):e27569. doi: 10.1097/MD.0000000000027569.
10
AMPK agonist alleviate renal tubulointerstitial fibrosis via activating mitophagy in high fat and streptozotocin induced diabetic mice.AMPK 激动剂通过激活高脂和链脲佐菌素诱导的糖尿病小鼠的自噬缓解肾间质纤维化。
Cell Death Dis. 2021 Oct 9;12(10):925. doi: 10.1038/s41419-021-04184-8.